40 participants
Phase II Clinical Trial of Interleukin-2 in AD
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-05-23
- Start Date:
- 2022-01-01
- Completion:
- 2025-12-30
Conditions
- Alzheimer Disease
Interventions
- DRUG
No Results Yet